Converting primary tumor towards an in situ STING-activating vaccine via a biomimetic nanoplatform against recurrent and metastatic tumors

Title
Converting primary tumor towards an in situ STING-activating vaccine via a biomimetic nanoplatform against recurrent and metastatic tumors
Authors
Keywords
Biomimetic nanoparticles, Cancer immunotherapy, Recurrent tumor, Metastatic tumor
Journal
Nano Today
Volume 38, Issue -, Pages 101109
Publisher
Elsevier BV
Online
2021-03-02
DOI
10.1016/j.nantod.2021.101109

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started